Bruker Corporation (BRKR)

Market Cap	11.00B
Revenue (ttm)	3.00B
Net Income (ttm)	401.60M
Shares Out	145.34M
EPS (ttm)	2.74
PE Ratio	27.62
Forward PE	24.57
Dividend	$0.20 (0.26%)
Ex-Dividend Date	Feb 29, 2024

Volume	1,065,612
Open	74.81
Previous Close	74.24
Day's Range	74.30 - 75.76
52-Week Range	53.79 - 94.86
Beta	1.22
Analysts	Buy
Price Target	85.67 (+13.22%)
Earnings Date	May 2, 2024

About BRKR

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related te...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 9,707
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR

Financial Performance

In 2023, Bruker's revenue was $2.96 billion, an increase of 17.14% compared to the previous year's $2.53 billion. Earnings were $427.20 million, an increase of 44.03%.

Analyst Forecast

According to 7 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $85.67, which is an increase of 13.22% from the latest price.

Price Target

$85.67

(13.22% upside)

Analyst Consensus: Buy